amrinone has been researched along with verapamil in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (34.48) | 18.7374 |
| 1990's | 7 (24.14) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 8 (27.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Junkin, P; Riley, CM | 1 |
| Parmley, WW; Wikman-Coffelt, J; Wu, ST | 1 |
| Alousi, AA; Johnson, DC | 1 |
| Galatulas, I; Gibelli, N; Supino, R; Zunino, F | 1 |
| Ceroni, G; Dorigo, P; Gaion, RM; Giacometti, A; Maragno, I | 1 |
| Kapur, PA; Makela, VH | 1 |
| Bonte, J; Col, J; Compere, A; Goenen, M | 1 |
| Alousi, AA; Canter, JM; Fort, DJ | 1 |
| Onuaguluchi, G; Tanz, RD | 1 |
| Kodama, I; Kondo, N; Shibata, S | 1 |
| Aronson, RS; Hertzberg, J; Nusrat, A; Sonnenblick, EH; Tepper, D | 1 |
| Buck, DC; Mielens, ZE | 1 |
| Otten, EJ; Spadafora, MP; Wolf, LR | 1 |
| Koury, SI; Stone, CK; Thomas, SH | 1 |
| Apaydin, S; Ates, M; Guven, H; Kalkan, S; Tuncok, Y | 1 |
| Apaydin, S; Ates, M; Gidener, S; Gure, A; Guven, H; Oto, O; Tuncok, Y | 1 |
| Hamilton, RJ; Manoach, SM | 1 |
1 review(s) available for amrinone and verapamil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
28 other study(ies) available for amrinone and verapamil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Stability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixtures.
Topics: Amrinone; Bicarbonates; Chromatography, High Pressure Liquid; Digoxin; Drug Combinations; Drug Incompatibility; Drug Stability; Potassium Chloride; Procainamide; Propranolol; Sodium; Sodium Bicarbonate; Verapamil | 1991 |
Intracellular endocardial calcium and myocardial function in rat hearts.
Topics: Adenosine; Amrinone; Animals; Calcium; Cyclic AMP; Diastole; Endocardium; Isoproterenol; Myocardial Contraction; Norepinephrine; Rats; Second Messenger Systems; Systole; Verapamil | 1991 |
Pharmacology of the bipyridines: amrinone and milrinone.
Topics: Acetylcholine; Aminopyridines; Amrinone; Animals; Calcium; Carbachol; Cardiotonic Agents; Cats; Cyclic AMP; Dibutyryl Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart; Hemodynamics; Ion Channels; Male; Milrinone; Myocardial Contraction; Norepinephrine; Potassium; Pyridones; Receptors, Muscarinic; Sodium; Stimulation, Chemical; Time Factors; Verapamil | 1986 |
Influence of calcium and calcium-modulating agents on differentiation of murine erythroleukaemia cells.
Topics: 4-Aminopyridine; Aminopyridines; Amrinone; Animals; Calcimycin; Calcium; Calcium Channel Blockers; Cell Differentiation; Cell Division; Cell Line; Dimethyl Sulfoxide; Egtazic Acid; Erythrocytes; Erythropoiesis; Friend murine leukemia virus; Gallic Acid; Leukemia, Erythroblastic, Acute; Mice; Razoxane; Verapamil | 1985 |
The role of calcium in amrinone action on intestinal smooth muscle.
Topics: Acetylcholine; Amrinone; Animals; Calcium; Female; Guinea Pigs; Ileum; In Vitro Techniques; Intestines; Male; Muscle Contraction; Muscle, Smooth; Verapamil | 1987 |
Amrinone and verapamil-propranolol induced cardiac depression during isoflurane anesthesia in dogs.
Topics: Amrinone; Anesthesia, Inhalation; Animals; Anti-Arrhythmia Agents; Dogs; Drug Interactions; Heart; Isoflurane; Propranolol; Verapamil | 1987 |
Treatment of severe verapamil poisoning with combined amrinone-isoproterenol therapy.
Topics: Adolescent; Amrinone; Drug Therapy, Combination; Humans; Isoproterenol; Male; Verapamil | 1986 |
The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Central Venous Pressure; Dogs; Female; Heart Failure; Male; Pentobarbital; Procainamide; Propranolol; Vascular Resistance; Verapamil | 1985 |
Electromechanical dissociation and possible uncoupling of phosphorylation following tachydysrhythmogenic dose of amrinone in the guinea-pig Langendorff heart preparation.
Topics: Aminopyridines; Amrinone; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Electrocardiography; Guinea Pigs; Heart; In Vitro Techniques; Myocardial Contraction; Myocardium; Oxidative Phosphorylation; Time Factors; Uncoupling Agents; Verapamil | 1984 |
Effects of amrinone on the transmembrane action potential of rabbit sinus node pacemaker cells.
Topics: Action Potentials; Aminopyridines; Amrinone; Animals; Calcium; Cardiotonic Agents; Female; Heart Conduction System; In Vitro Techniques; Male; Pindolol; Rabbits; Verapamil | 1983 |
Effects of amrinone on atrioventricular conduction in the intact canine heart.
Topics: Aminopyridines; Amrinone; Animals; Bundle of His; Cardiotonic Agents; Dogs; Heart Conduction System; Ouabain; Propranolol; Sinoatrial Node; Verapamil | 1983 |
Relaxant effects of amrinone upon pulmonary smooth muscle.
Topics: Airway Resistance; Aminophylline; Aminopyridines; Amrinone; Animals; Barium; Calcium; Carbachol; Drug Interactions; Guinea Pigs; Histamine Antagonists; In Vitro Techniques; Lung; Muscle Relaxation; Muscle, Smooth; Verapamil | 1982 |
Use of amrinone and glucagon in a case of calcium channel blocker overdose.
Topics: Adult; Amrinone; Drug Overdose; Drug Therapy, Combination; Female; Glucagon; Humans; Hypotension; Verapamil | 1993 |
Amrinone as an antidote in experimental verapamil overdose.
Topics: Amrinone; Animals; Antidotes; Dogs; Drug Overdose; Hemodynamics; Verapamil | 1996 |
The effects of amrinone and glucagon on verapamil-induced cardiovascular toxicity in anaesthetized rats.
Topics: Amrinone; Animals; Blood Pressure; Bradycardia; Calcium Channel Blockers; Cardiovascular Diseases; Drug Combinations; Glucagon; Heart Rate; Hypotension; Male; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Verapamil | 1996 |
The effects of amrinone and glucagon on verapamil-induced myocardial depression in a rat isolated heart model.
Topics: Amrinone; Animals; Calcium Channel Blockers; Depression, Chemical; Glucagon; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Verapamil | 1997 |
Amrinone and verapamil overdose study design.
Topics: Amrinone; Animals; Antidotes; Dogs; Drug Overdose; Research Design; Verapamil | 1997 |